Optimizing Palbociclib Therapy Across the Age Spectrum: Hypothetical, Illustrative Case Scenarios in HR+, HER2–Metastatic Breast Cancer

por Podsada, Kimberly, Ryan, Joanne C., Orbaugh, Kristi
Publicado 2020

Predictors of Practice Patterns for Lymphedema Care Among Oncology Advanced Practice Nurses

por Ryan, Joanne C., Cleland, Charles M., Fu, Mei R.
Publicado 2012

Role of the Advanced Practice Provider in Clinical Trials: Contributions to the Management of Patients Receiving Inotuzumab Ozogamicin

por Welch, Mary Alma, Ryan, Joanne C., Galinsky, Ilene Ann
Publicado 2017

Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario

por Roethke, Susan K., Ryan, Joanne C., Wood, Sarah Yenser
Publicado 2018

Updates on managing advanced breast cancer with palbociclib combination therapy

por McShane, Teresa M., Wolfe, Thomas A., Ryan, Joanne C.
Publicado 2018

Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scen...

por Allman, Kimberly D., Ryan, Joanne C., Clair, Andrew, Yenser-Wood, Sarah
Publicado 2019

Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice

por Mayden, Kelley D., Kelton, John M., Ryan, Joanne C., McBride, Ali
Publicado 2022

Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving Talazoparib

por Martinez, Ashley, Jones, Tiffany, Ryan, Joanne C., Barnett, Chad M., Soussou, Elpitha L., Donahue, Sarah
Publicado 2022

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

por Savill, Kristin M Zimmerman, Ivanova, Jasmina, Asgarisabet, Parisa, Falkenstein, Angelica, Balanean, Alexandrina, Niyazov, Alexander, Ryan, Joanne C, Kish, Jonathan, Gajra, Ajeet, Mahtani, Reshma L
Publicado 2023

Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists

por Relias, Valerie, McBride, Ali, Newman, Matthew J, Paul, Shilpa, Saneeymehri, Seyyedeh, Stanislaus, Genique, Tobin, Jennifer, Hoang, Caroline J, Ryan, Joanne C, Galinsky, Ilene
Publicado 2020